88 results
8-K
EX-1.1
AQST
Aquestive Therapeutics Inc
21 Mar 24
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
4:06pm
assessment, fine or penalty levied against them (except for any such taxes, assessments fines or penalties currently being contested in good faith
8-K
EX-10.1
ydxxgec
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-10.3
jwmsnfk47gx955f
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-10.2
2d10awpj2
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-99.1
qk2 wiy7ky
11 Aug 23
Advancing medicines. Solving problems. Improving lives. Advancing medicines. Solving problems. Improving lives. Corporate Presentation August 2023 1
1:14pm
S-8
EX-4.1
nys71
9 Aug 23
Registration of securities for employees
5:22pm
8-K
EX-99.1
70i0r
27 Jul 23
Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylm™ (epinephrine) Sublingual Film
9:23am
8-K
EX-99.1
p9chjgll6z 46r8m6
29 Jun 23
Advancing medicines. Solving problems. Improving lives. Corporate Presentation June 2023 1
9:05am
PRE 14A
szcsh
18 Apr 23
Preliminary proxy
8:50am
8-K
EX-99.1
bigspwhd37yscji
10 Aug 22
Unregistered Sales of Equity Securities
5:15pm